How to Value a Physician Practice Management Firm in 2026

Let me start with an important clarification, because this category is one of the most confused in healthcare M&A. When I say "physician practice management firm" in this guide, I'm talking about consulting and advisory businesses that help independent physician practices run better — not the PE-backed practice management organizations (like those rolling up dermatology, orthopedics, or GI) that own the underlying medical practices. Those are entirely different businesses with entirely different valuation math.

The consulting version of practice management is a services business. You charge fees to physician practices for operations support, compliance advisory, payer contracting help, EHR optimization, workflow redesign, or fractional CFO/COO services. And because most of these firms are owner-operated and under $2M in revenue, they're typically valued on SDE, not EBITDA, at multiples of 2.5-5x depending on the mix of recurring versus project work.

Why SDE Instead of EBITDA

Practice management consulting firms are usually structured around one or two senior consultants (often the founder) doing most of the client-facing work. Annual revenue typically runs $500K-$2.5M, EBITDA is modest because the founder takes most of the cash out as salary and distributions, and the business effectively provides a job plus some operating profit.

That profile is exactly why SDE is the right metric. SDE adds back the owner's compensation, benefits, and perks to show total cash flow available to a new owner-operator — which is how buyers in this category actually think about the purchase. For more on the distinction, see SDE vs EBITDA.

Typical ranges I see:

• Project-heavy firms, sub-$300K SDE: 2-3x SDE. Essentially buying a job.
• Mixed project/recurring, $300K-$600K SDE: 3-4x SDE.
• Recurring-heavy, $500K-$1M SDE: 3.5-4.5x SDE.
• Strong recurring base, specialty focus, $1M+ SDE: 4-5x SDE, with occasional step-ups to EBITDA-based valuation as the business crosses $1.5M in EBITDA and becomes interesting to lower-middle-market PE.

Recurring vs Project Is the Biggest Lever

The single variable that drives valuation in this category is revenue mix. A firm doing $1M in one-off project revenue (EHR implementations, compliance audits, practice assessments, payer contract negotiations) is worth maybe 2.5x SDE because every dollar of revenue has to be resold next year. A firm doing $1M in recurring monthly retainer revenue (fractional COO, ongoing compliance monitoring, monthly financial advisory) is worth 4-4.5x SDE because the revenue is predictable.

The gap is enormous. On $500K SDE, that's the difference between a $1.25M sale and a $2.25M sale — same work, same people, just structured differently. The owners who understand this shift their business model 2-3 years before selling and capture the multiple expansion.

The practical playbook: move as many clients as possible from project engagements to retainer relationships. A $15,000 one-time practice assessment becomes a $2,500 monthly ongoing advisory relationship. The lifetime value is higher, the work is less intense, and most importantly, the business is worth more at sale.

Specialty Focus Commands Premiums

Generalist practice management firms — "we help any physician practice with anything" — struggle to command top-of-range multiples because buyers see them as dependent on the founder's relationships and general expertise. Specialty- focused firms get meaningfully higher valuations.

The specialties that command the strongest premiums in 2026:

• Ophthalmology and optometry practice management: Active PE consolidation (EyeCare Partners, Acuity Eyecare Group, US Eye) has created demand for specialized advisory firms.
• Dermatology practice management: Heavy rollup activity (Advanced Dermatology, Schweiger Dermatology, Epiphany Dermatology) drives demand for specialized operators and advisors.
• Orthopedics and musculoskeletal: Bundled payment complexity, ASC integration, and PE platform activity (US Orthopaedic Partners, OrthoAlliance) create consulting demand.
• GI and ASC management: GI Alliance, US Digestive Health, and One GI have driven consolidation, and specialty-aware consulting firms are in demand.
• Behavioral health and psychiatry: The mix of telehealth, payer dynamics, and compliance makes specialty advisors valuable.

A practice management firm with deep specialty expertise in one of these areas can get 4.5-5x SDE (versus 3-3.5x for generalists) because the knowledge is defensible and the client universe is expanding through rollup activity.

Who's Buying These Firms

The buyer pool is narrower than for billing or RCM, but real:

• Larger healthcare consulting firms: ECG Management Consultants, Coker Group, HSG Advisors, and Veralon acquire specialized practices to add capability and client relationships. They pay 3.5-5x SDE or 5-7x EBITDA for larger firms.
• PE-backed specialty platforms: Occasionally acquire advisory firms to internalize expertise — dermatology platforms hiring dermatology-focused consultants, for example. These are opportunistic but can pay well.
• Individual buyers and search funders: The most common buyer for sub-$500K SDE firms. They're buying themselves a job with profit margin, and they pay 2.5-3.5x SDE with seller financing.
• Strategic buyers adjacent to healthcare: Law firms, accounting firms, and healthcare technology companies occasionally acquire practice management consultancies to deepen healthcare capability.

What Kills These Deals

The classic failure modes:

Owner IS the business. If clients hired you personally and won't stay with anyone else, you're not selling a business — you're selling a phone number. Buyers know this and discount heavily. The fix is to build a junior consultant team that handles 40%+ of client-facing work and to document institutional knowledge in playbooks.

Lumpy revenue. A firm with three big projects a year that together produce $800K in revenue looks great until a buyer sees the quarterly revenue chart and realizes it's feast-or-famine. Even if the annual total is strong, the volatility depresses multiples. Recurring revenue smooths the line and buyers pay for smooth lines.

Informal engagements. If half your client work happens on handshake deals without formal statements of work or written retainer agreements, buyers will discount the revenue during diligence. Get everything papered before going to market.

Referral dependence. If 80% of new business comes from the founder's personal network, the business doesn't have independent go-to-market capability. Building even a modest content marketing effort, referral program, or junior sales role demonstrates transferable pipeline. Related: building transferable pipeline before a sale.

Moving Your Multiple Higher

The 24-month pre-sale playbook for practice management consulting firms:

Convert project work to retainers. This is the single highest- leverage action. Every recurring dollar is worth 1.5-2x what a project dollar is worth at sale. Offer clients discounted rates for 12-month commitments.

Hire and document a number two. A senior consultant who can handle client relationships independently removes the key person discount. Even if you lose some margin paying the second seat, the multiple expansion more than compensates.

Pick a specialty. Rebrand around one or two specialties and build content, case studies, and thought leadership in that niche. Generalists are commodity; specialists are premium.

Formalize your methodology. Turn your implicit approach into a documented methodology with playbooks, templates, and training materials. Buyers pay for transferable IP, even in consulting.

Clean books and contracts. Reviewed financials for three years, written retainer agreements for all recurring clients, and clean expense categorization. Small stuff that makes due diligence painless.

The Bottom Line

Physician practice management consulting isn't a high-multiple business, but it's a legitimately sellable one when structured well. The owners who get clean 3.5-5x SDE exits are the ones who build recurring revenue, develop specialty focus, document their methodology, and reduce owner dependence. The ones who stay generalist, project-driven, and founder-centric struggle to find buyers at any price. The good news is that the fixes are within your control, and 24 months of focused preparation can materially change your outcome.